Vergent Bioscience, Inc.
5 private offerings reported to the SEC on Form D since 2016, $57.0M sold in all. Biotech, MN.
- Form D offerings: 5
- Reported sold: $57.0M
- Newest: Oct 20, 2025
Every Form D Offering
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.| Oct 20, 2025 | $18.7M | $32.0M | Vergent Bioscience, Inc.Biotech · MN | Not amended | 0001741495-25-000004 |
| Feb 18, 2025 | $3.8M | $5.0M | Vergent Bioscience, Inc.Biotech · MN | Not amended | 0001741495-25-000001 |
| Oct 4, 2022 | $21.5M | $22.1M | Vergent Bioscience, Inc.Biotech · MN | Not amended | 0001741495-22-000001 |
| Nov 22, 2021 | $1.2M | $2.0M | Vergent Bioscience, Inc.Biotech · MN | Not amended | 0001741495-21-000001 |
| Jun 1, 2018 | $11.9M | $11.9M | Vergent Bioscience, Inc.Biotech · MN | Sep 23, 2020 | 0001741495-18-000001 |
SEC Profile
From the company's EDGAR record- Business address
- Minneapolis, Mn
- Incorporated in
- DE
- All SEC filings
- CIK 1741495 on EDGAR
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR